231 results on '"Viallard, Jean-Francois"'
Search Results
2. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes
3. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
4. Pregnancy in primary immunodeficiency diseases: The PREPI study
5. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies
6. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
7. Early-onset autoimmunity associated with SOCS1 haploinsufficiency.
8. Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study
9. Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity
10. Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
11. Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
12. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
13. Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
14. A French cohort for assessing COVID-19 vaccine responses in specific populations
15. “Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients
16. Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
17. One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort
18. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France
19. Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications
20. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
21. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants
22. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.
23. Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
24. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
25. Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents
26. Multirefractory Primary Immune Thrombocytopenia in Adults: Prevalence and Burden. Results from the Carmen-France Registry
27. Platelet Count Threshold Associated with Bleeding in Adult Patients with Immune Thrombocytopenia Treated with Antiplatelet Drugs. Results from the Carmen-France Registry
28. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort
29. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
30. ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry
31. Perturbations of the CD8+ T-cell repertoire in CVID patients with complications
32. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines
33. The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
34. Chapitre 35 - Les déficits immunitaires de l’adulte
35. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome
36. Late-Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency with Severe T Cell Defect
37. Infections in 252 Patients with Common Variable Immunodeficiency
38. Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
39. Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment
40. Romiplostim for the Treatment of Adult Patients with Newly Diagnosed or Persistent Immune Thrombocytopenia: Subgroup Analysis from a Phase 2 Study
41. Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France
42. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
43. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura
44. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
45. Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients
46. Autoimmune Disorders and Quadrivalent Human Papillomavirus Vaccination of Young Females: 415.
47. Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016
48. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort
49. Lymphadénite histiocytaire nécrosante ou maladie de Kikuchi-Fujimoto
50. Leucémies à grands lymphocytes granuleux
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.